{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:48:06Z","timestamp":1781740086277,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.transproceed.2021.08.052","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:57:34Z","timestamp":1636505854000},"page":"3022-3029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of Anti-HLA De Novo Donor Specific Antibody on Graft Outcomes in Pancreas Transplantation: A Meta-Analysis"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6665-0669","authenticated-orcid":false,"given":"Sualeh Muslim","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3656-9197","authenticated-orcid":false,"given":"Ramish","family":"Sumbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin D.","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2021.08.052_bib0001","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/SLA.0b013e3181b76d2b","article-title":"One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up","volume":"250","author":"Sollinger","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0002","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1755-6686.2012.00269.x","article-title":"Simultaneous pancreas and kidney transplantation in diabetes with renal failure: the gold standard?","volume":"38","author":"Augustine","year":"2012","journal-title":"J Ren Care"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0003","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1007\/s00125-013-2888-y","article-title":"Improved patient survival with simultaneous pancreas and kidney transplantation in recipients with diabetic end-stage renal disease","volume":"56","author":"Lindahl","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0004","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ajt.15673","article-title":"OPTN\/SRTR 2018 annual data report: pancreas","volume":"20","author":"Kandaswamy","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0005","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/ajt.12167","article-title":"Acute pancreas allograft rejection is associated with increased risk of graft failure in pancreas transplantation","volume":"13","author":"Dong","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0006","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MOT.0b013e3283614a5c","article-title":"Pancreas transplantation, antibodies and rejection: where do we stand?","volume":"18","author":"de Kort","year":"2013","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0007","series-title":"Transplantation pathology","first-page":"249","article-title":"Pancreas transplantation pathology","author":"Drachenberg","year":"2009"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0008","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1399-0012.2011.01440.x","article-title":"Eosinophilia as an early indicator of pancreatic allograft rejection","volume":"26","author":"Weir","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0009","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/TP.0b013e3181dda17e","article-title":"Pancreas allograft rejection: analysis of concurrent renal allograft biopsies and posttherapy follow-up biopsies","volume":"90","author":"Troxell","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0010","first-page":"330","article-title":"Experimental pancreas allograft rejection: correlation between histologic and functional rejection and the efficacy of antirejection therapy","volume":"98","author":"Schulak","year":"1985","journal-title":"Surgery"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0011","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0041-1345(96)00395-8","article-title":"Correlation of serologic and urinary tests with allograft biopsy in the diagnosis of pancreas rejection","volume":"29","author":"Gill","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0012","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0013","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1111\/j.1600-6143.2012.04251.x","article-title":"Posttransplant de novo donor-specific HLA antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection","volume":"12","author":"Ginevri","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0014","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1111\/j.1600-6143.2011.03729.x","article-title":"Posttransplant donor-specific anti-HLA antibodies negatively impact pancreas transplantation outcome","volume":"11","author":"Cantarovich","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0015","doi-asserted-by":"crossref","first-page":"E492","DOI":"10.1111\/ctr.12005","article-title":"Early findings of prospective anti-HLA donor specific antibodies monitoring study in pancreas transplantation: Indiana University Health Experience","volume":"26","author":"Mujtaba","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0017","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et\u00a0al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, < http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp >; 2014 [accessed 20.01.10]."},{"key":"10.1016\/j.transproceed.2021.08.052_bib0018","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0019","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/tri.12687","article-title":"Impact of de novo donor-specific anti-HLA antibodies on grafts outcomes in simultaneous pancreas\u2013kidney transplantation","volume":"29","author":"Malheiro","year":"2016","journal-title":"Transplant Int"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0021","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1111\/ajt.12750","article-title":"De novo donor-specific HLA antibodies: biomarkers of pancreas transplant failure","volume":"14","author":"Mittal","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0022","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1056\/NEJMoa1302506","article-title":"Complement-binding anti-HLA antibodies and kidney-allograft survival","volume":"369","author":"Loupy","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0023","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1681\/ASN.2014040399","article-title":"Subclinical rejection phenotypes at 1 year post-transplant and outcome of kidney allografts","volume":"26","author":"Loupy","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0024","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrneph.2012.81","article-title":"The impact of donor-specific anti-HLA antibodies on late kidney allograft failure","volume":"8","author":"Loupy","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0025","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.healun.2016.10.016","article-title":"Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation","volume":"36","author":"Clerkin","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0026","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.healun.2016.05.020","article-title":"De-novo donor-specific anti-HLA antibodies 30 days after lung transplantation are associated with a worse outcome","volume":"35","author":"Le Pavec","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0027","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/849835","article-title":"Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation","volume":"2013","author":"Lionaki","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0028","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/PAP.0b013e3181d97635","article-title":"Pancreas transplant: Recent advances and spectrum of features in pancreas allograft pathology","volume":"17","author":"Patil","year":"2010","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0029","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2215\/CJN.00700117","article-title":"Donor-specific antibodies in kidney transplant recipients","volume":"13","author":"Zhang","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0030","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/j.1600-6143.2011.03670.x","article-title":"Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts\u2014updated Banff grading schema","volume":"11","author":"Drachenberg","year":"2011","journal-title":"Am J Transplan"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0031","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01248-2017","article-title":"Donor-specific and-nonspecific HLA antibodies and outcome post lung transplantation","volume":"50","author":"Verleden","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0032","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/tri.12887","article-title":"De novo donor-specific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability","volume":"30","author":"Kauke","year":"2017","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0033","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.3727\/096368916X691673","article-title":"Immunogenicity of anti-HLA antibodies in pancreas and islet transplantation","volume":"25","author":"Chaigne","year":"2016","journal-title":"Cell Transplant"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0034","doi-asserted-by":"crossref","first-page":"e13785","DOI":"10.1111\/ctr.13785","article-title":"Eosinophil-to-monocyte ratio is an excellent predictor of acute cellular rejection in pancreas transplant alone recipients","volume":"34","author":"Ryu","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40472-015-0061-x","article-title":"Diagnosis and treatment of pancreas rejection","volume":"2","author":"Redfield","year":"2015","journal-title":"Curr Transplant Rep"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0036","doi-asserted-by":"crossref","first-page":"e13998","DOI":"10.1111\/ctr.13998","article-title":"Anti-HLA donor specific antibody monitoring in pancreas transplantation: role of protocol biopsies","author":"Uva","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0037","doi-asserted-by":"crossref","first-page":"S448","DOI":"10.1097\/01.tp.0000543238.92801.20","article-title":"Antibody monitoring in pancreas transplantation: when should we do protocol biopsies?","volume":"102","author":"Uva","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0038","first-page":"435","article-title":"Outcomes of pancreas transplant recipients with de novo donor-specific antibodies","volume":"103","author":"Parajuli","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0039","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/j.transproceed.2015.09.013","article-title":"A single-center experience on the value of pancreas graft biopsies and HLA antibody monitoring after simultaneous pancreas-kidney transplantation","volume":"47","author":"Becker","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2021.08.052_bib0040","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1111\/j.1600-6143.2010.03079.x","article-title":"Pancreas allograft biopsies with positive C4d staining and anti-donor antibodies related to worse outcome for patients","volume":"10","author":"de Kort","year":"2010","journal-title":"Am J Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521007090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521007090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:40:36Z","timestamp":1758577236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134521007090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0041134521007090"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.08.052","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Anti-HLA De Novo Donor Specific Antibody on Graft Outcomes in Pancreas Transplantation: A Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.08.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}